RAB22A as a predictor of exosome secretion in the progression and relapse of multiple myeloma
Aging · 2024
DOI: 10.18632/aging.205565 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging, 2024. Verfasst von Bingjie Fan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Affiliated Hospital of Guizhou Medical University, Guizhou Province Institute of Hematology, Guizhou Province Laboratory of…. Hauptthemen laut MEDLINE: Multiple Myeloma, Exosomes, Monoclonal Gammopathy of Undetermined Significance. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
BACKGROUND: Multiple myeloma (MM) is an incurable malignant plasma cell disease. We explored the role of RAB22A in exosome secretion, epithelial-mesenchymal transition (EMT) and immune regulation. METHODS: We obtained MM samples from Gene Expression Omnibus (GEO) data sets. We downloaded the "IOBR" package, and used the "PCA" and "ssGSEA" algorithms to calculate the EMT scores and exosome scores. The "CIBERSORT" package was used to analyze the infiltration of immune cells. We extracted the exosomes of mesenchymal stem cell (MSC) to verify the biological function of RAB22A. RESULTS: The expression level of RAB22A in smoldering multiple myeloma (SMM) and MM patients was significantly higher than that in normal people and monoclonal gammopathy of undetermined significance (MGUS) patients, and the expression level of RAB22A in relapse MM patients was significantly higher than that in newly diagnosed patients. The EMT scores and exosome scores of high RAB22A group were significantly higher than those of low RAB22A group, and the exosome scores of MSC in recurrent patients were significantly higher than those of newly diagnosed patients. In addition, the infiltration levels of monocyte, NK cells resting, eosinophils, T cells regulatory and T cells CD4 memory activated were positively correlated with RAB22A. After down-regulating the expression of RAB22A in MM-MSC, the secretion of exosomes decreased. Compared with the exosomes of MSC in si-RAB22A group, the exosomes in control group significantly promoted the proliferation of MM. CONCLUSIONS: RAB22A is a potential therapeutic target to improve the prognosis of MM, which is closely related to exosome secretion, EMT and immune cell infiltration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology, Affiliated Hospital of Guizhou Medical University, Guizhou Province Institute of Hematology, Guizhou Province Laboratory of Hematopoietic Stem Cell Transplantation Centre, Guiyang, China.
- Clinical Medicine College of Guizhou Medical University, Guiyang, China.
Zitieren
APA
Fan, B., Wang, L., & Wang, J. (2024). RAB22A as a predictor of exosome secretion in the progression and relapse of multiple myeloma. Aging. https://doi.org/10.18632/aging.205565
Vancouver
Fan B, Wang L, Wang J. RAB22A as a predictor of exosome secretion in the progression and relapse of multiple myeloma. Aging. 2024. doi:10.18632/aging.205565
BibTeX
@article{Fan2024,
author = {Fan, Bingjie and Wang, Li and Wang, Jishi},
title = {RAB22A as a predictor of exosome secretion in the progression and relapse of multiple myeloma},
journal = {Aging},
year = {2024},
doi = {10.18632/aging.205565}
}
EUVIMED